Andy Chevigné

2.3k total citations
76 papers, 1.5k citations indexed

About

Andy Chevigné is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Andy Chevigné has authored 76 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 37 papers in Molecular Biology and 33 papers in Immunology. Recurrent topics in Andy Chevigné's work include Chemokine receptors and signaling (41 papers), Receptor Mechanisms and Signaling (24 papers) and Immunotherapy and Immune Responses (19 papers). Andy Chevigné is often cited by papers focused on Chemokine receptors and signaling (41 papers), Receptor Mechanisms and Signaling (24 papers) and Immunotherapy and Immune Responses (19 papers). Andy Chevigné collaborates with scholars based in Luxembourg, Belgium and Germany. Andy Chevigné's co-authors include Martyna Szpakowska, Max Meyrath, Jean-Claude Schmit, Julien Hanson, Moreno Galleni, Virginie Fiévez, Brian F. Volkman, Andrew B. Kleist, Alain Jacquet and Nadine Dupuis and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Andy Chevigné

74 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andy Chevigné Luxembourg 24 668 626 581 210 155 76 1.5k
F. Boulay France 12 251 0.4× 757 1.2× 656 1.1× 147 0.7× 123 0.8× 15 1.2k
Knut Martin Torgersen Norway 24 460 0.7× 1.1k 1.8× 1.1k 1.9× 116 0.6× 94 0.6× 39 2.4k
Eric Wakshull United States 24 211 0.3× 841 1.3× 594 1.0× 218 1.0× 462 3.0× 50 1.7k
Kerry Kelleher United States 18 321 0.5× 831 1.3× 484 0.8× 86 0.4× 156 1.0× 26 1.8k
Mark E. DeVries Canada 15 379 0.6× 501 0.8× 557 1.0× 194 0.9× 49 0.3× 19 1.1k
Anthony J. Jurewicz United States 14 332 0.5× 356 0.6× 537 0.9× 70 0.3× 61 0.4× 20 1.2k
Sylvia L. Anderson United States 19 238 0.4× 832 1.3× 743 1.3× 343 1.6× 91 0.6× 37 1.9k
Janet Weinstock Australia 20 334 0.5× 514 0.8× 265 0.5× 253 1.2× 162 1.0× 35 1.3k
Hanne L. Ostergaard Canada 26 343 0.5× 1.1k 1.8× 1.2k 2.1× 71 0.3× 144 0.9× 49 2.3k
Flavia Castellano France 22 300 0.4× 558 0.9× 717 1.2× 61 0.3× 44 0.3× 51 1.7k

Countries citing papers authored by Andy Chevigné

Since Specialization
Citations

This map shows the geographic impact of Andy Chevigné's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Chevigné with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Chevigné more than expected).

Fields of papers citing papers by Andy Chevigné

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Chevigné. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Chevigné. The network helps show where Andy Chevigné may publish in the future.

Co-authorship network of co-authors of Andy Chevigné

This figure shows the co-authorship network connecting the top 25 collaborators of Andy Chevigné. A scholar is included among the top collaborators of Andy Chevigné based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy Chevigné. Andy Chevigné is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bosma, Reggie, Max Meyrath, Susanne M. A. van der Pol, et al.. (2025). Inhibition of constitutive activity of the atypical chemokine receptor 3 by the small-molecule inverse agonist VUF16840. Molecular Pharmacology. 107(12). 100085–100085. 1 indexed citations
2.
Deflorian, Francesca, Chris de Graaf, Martyna Szpakowska, et al.. (2025). Design, Synthesis and Pharmacological Characterization of the First Photoswitchable Small-Molecule Agonist for the Atypical Chemokine Receptor 3. ACS Omega. 10(8). 8675–8686.
3.
Szpakowska, Martyna, Daniel F. Legler, Stefan Offermanns, et al.. (2025). Inclusion of ACKR5 in the systematic nomenclature of atypical chemokine receptors. Nature reviews. Immunology. 25(3). 225–226. 2 indexed citations
4.
Noman, Muhammad Zaeem, Martyna Szpakowska, Malina Xiao, et al.. (2025). Targeting the atypical chemokine receptor 2 ( Ackr2 ) improves the benefit of anti-PD-1 immunotherapy in melanoma mouse model. OncoImmunology. 14(1). 2494426–2494426.
5.
6.
Zacarı́as, Natalia V. Ortiz, S. Nasser, Stephan Scholl, et al.. (2024). Fluorophore-Labeled Pyrrolones Targeting the Intracellular Allosteric Binding Site of the Chemokine Receptor CCR1. ACS Pharmacology & Translational Science. 7(7). 2080–2092. 4 indexed citations
7.
Chevigné, Andy, et al.. (2023). Cannabidiol negatively modulates adenosine A2A receptor functioning in living cells. Acta Neuropsychiatrica. 36(5). 320–324. 3 indexed citations
8.
Kleist, Andrew B., Andrija Sente, Martyna Szpakowska, et al.. (2022). Conformational selection guides β-arrestin recruitment at a biased G protein–coupled receptor. Science. 377(6602). 222–228. 25 indexed citations
9.
Torrent, Claudia Llinás del, Andy Chevigné, Víctor Fernández‐Dueñas, et al.. (2022). The ADORA1 mutation linked to early-onset Parkinson’s disease alters adenosine A1-A2A receptor heteromer formation and function. Biomedicine & Pharmacotherapy. 156. 113896–113896. 7 indexed citations
10.
Baba, Osamu, Andrew Elvington, Martyna Szpakowska, et al.. (2020). CXCR4-Binding Positron Emission Tomography Tracers Link Monocyte Recruitment and Endothelial Injury in Murine Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 41(2). 822–836. 16 indexed citations
11.
Hjortø, Gertrud M., Francis C. Peterson, Martyna Szpakowska, et al.. (2020). Structural Features of an Extended C-Terminal Tail Modulate the Function of the Chemokine CCL21. Biochemistry. 59(13). 1338–1350. 10 indexed citations
12.
Collins, Paul J., Mieke Metzemaekers, Max Meyrath, et al.. (2020). CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems. Frontiers in Immunology. 11. 561404–561404. 22 indexed citations
13.
Sjöberg, Elin, Max Meyrath, Laura Milde, et al.. (2019). A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer. Clinical Cancer Research. 25(12). 3702–3717. 87 indexed citations
14.
Wouters, Elise, Michael J. Robertson, Max Meyrath, et al.. (2019). Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds. ACS Pharmacology & Translational Science. 3(2). 285–295. 49 indexed citations
15.
Arendt, Vic, Gilles Iserentant, Gilles Ndayisaba, et al.. (2019). Predominance of the heterozygous CCR5 delta‐24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surface. Journal of the International AIDS Society. 22(9). e25384–e25384. 10 indexed citations
16.
17.
Szpakowska, Martyna, Nadine Dupuis, Alessandra Baragli, et al.. (2016). Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7. Biochemical Pharmacology. 114. 14–21. 34 indexed citations
18.
19.
Chevigné, Andy, et al.. (2010). Comparative study of mature and zymogen mite cysteine protease stability and pH unfolding. Biochimica et Biophysica Acta (BBA) - General Subjects. 1800(9). 937–945. 7 indexed citations
20.
Chevigné, Andy, D. Dehareng, Patrice Filée, et al.. (2007). Relationship between Propeptide pH Unfolding and Inhibitory Ability during ProDer p 1 Activation Mechanism. Journal of Molecular Biology. 374(1). 170–185. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Boulay Breakdown of academic impact, for papers by Knut Martin Torgersen Breakdown of academic impact, for papers by Eric Wakshull Breakdown of academic impact, for papers by Kerry Kelleher Breakdown of academic impact, for papers by Mark E. DeVries Breakdown of academic impact, for papers by Anthony J. Jurewicz Breakdown of academic impact, for papers by Sylvia L. Anderson Breakdown of academic impact, for papers by Janet Weinstock Breakdown of academic impact, for papers by Hanne L. Ostergaard Breakdown of academic impact, for papers by Flavia Castellano
Rankless by CCL
2026